Zoetis Inc. (NYSE:ZTS) Shares Purchased by Telos Capital Management Inc.

Telos Capital Management Inc. raised its position in Zoetis Inc. (NYSE:ZTS) by 9.6% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 40,179 shares of the company’s stock after buying an additional 3,505 shares during the period. Telos Capital Management Inc.’s holdings in Zoetis were worth $6,965,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Webster Bank N. A. increased its position in shares of Zoetis by 89.1% during the first quarter. Webster Bank N. A. now owns 174 shares of the company’s stock worth $29,000 after purchasing an additional 82 shares in the last quarter. Private Wealth Management Group LLC acquired a new stake in shares of Zoetis in the fourth quarter valued at about $33,000. Gladius Capital Management LP purchased a new position in shares of Zoetis in the fourth quarter worth about $40,000. Neo Ivy Capital Management acquired a new position in Zoetis during the fourth quarter worth about $40,000. Finally, LRI Investments LLC purchased a new stake in Zoetis during the 1st quarter valued at about $43,000. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on ZTS shares. Piper Sandler boosted their target price on Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, August 14th. The Goldman Sachs Group cut their target price on Zoetis from $223.00 to $196.00 and set a “buy” rating for the company in a research note on Monday, May 6th. Stifel Nicolaus reissued a “buy” rating and issued a $200.00 price objective on shares of Zoetis in a report on Tuesday, August 27th. BTIG Research lifted their target price on shares of Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, August 12th. Finally, HSBC cut their price target on shares of Zoetis from $230.00 to $225.00 and set a “buy” rating for the company in a report on Wednesday, May 8th. Nine analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Zoetis presently has a consensus rating of “Buy” and an average target price of $217.11.

Zoetis Trading Up 0.3 %

NYSE ZTS traded up $0.60 on Friday, reaching $183.49. The stock had a trading volume of 2,328,501 shares, compared to its average volume of 1,810,009. The company has a quick ratio of 2.09, a current ratio of 3.45 and a debt-to-equity ratio of 1.32. The stock has a fifty day moving average price of $179.83 and a two-hundred day moving average price of $174.54. Zoetis Inc. has a 12-month low of $144.80 and a 12-month high of $201.92. The firm has a market capitalization of $83.13 billion, a price-to-earnings ratio of 35.35, a P/E/G ratio of 2.81 and a beta of 0.86.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $1.56 EPS for the quarter, beating the consensus estimate of $1.49 by $0.07. The business had revenue of $2.36 billion during the quarter, compared to analyst estimates of $2.31 billion. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The business’s revenue for the quarter was up 8.3% compared to the same quarter last year. During the same quarter last year, the firm posted $1.41 earnings per share. As a group, sell-side analysts forecast that Zoetis Inc. will post 5.84 EPS for the current fiscal year.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.